Mechanism of proteinase complex formation with α2-macroglobulin Three modes of trypsin binding by Sottrup-Jensen, Lars et al.
Volume 128, number 1 FEBS LETTERS June 1981 
MECHANISM OF PROTEINASE COMPLEX FORMATION WITH a,-MACROGLOBULIN 
Three modes of trypsin binding 
Lars SOTTRUP-JENSEN, Torben E. PETERSEN and Staffan MAGNUSSON 
Department of Molecular Biology, University of Aarhus, 8000 Aarhus ( c. Denmark 
Received 30 March 1981 
1. Introduction 
The tetrameric plasmaglycoprotein a*-macroglob- 
ulin (oL~M), M, 725 000, forms complexes with pro- 
teinases from all 4 classes (EC 3.4.21-24) [l-3] that 
retain proteolytic activity towards small substrates 
[4-61. Complex formation is initiated by proteolytic 
cleavage in the ‘bait’ region near the middle of the 4 
identical Mr 180 000 subunits [ l-3,7-9] at sites, 
which reflect the specificity of the particular protein- 
ase [IO]. The initial complex is rearranged into the 
final aaM-proteinase complex which involves differ- 
ent binding sites on both oc,M and the proteinase [lo]. 
It has been suggested [9,1 l] that czZM may bind more 
trypsin molecules than the 2/mol a,M that can be 
protected from inhibition by ST1 [8,9,12,13]. 
As shown in [ 131 cwzM contains a thiol ester in each 
of its 4 subunits. This thiol ester involves the y-car- 
boxy1 group of a Glx-residue and the sulfhydryl group 
of a Cys-residue, located as residues -472 and -469, 
respectively, from the C-terminus of (YZM [ 141. During 
complex formation with proteinases the thiol esters 
are cleaved, resulting in the appearance of free SH- 
groups [ 133. ‘Inactivation’ of the proteinase-binding 
capacity of CQM by CH,NH2 also leads to cleavage of 
the thiol esters [ 131. During this process CH3NH, 
reacts covalently with the Glx-residues to form 4 res- 
idues of y-glutamylmethylamide at complete ‘inacti- 
vation’ [13-151. Since methylamine and putrescine 
readily become covalently incorporated in nascent 
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ol,M-trypsin complex 161 it appears that activated 
azM can participate in ‘acyl transfer’reactions [ 13,161, 
which has also been suggested for the complement 
components C3 [ 17-2 l] and C4 [ 221. The complexes 
that CQM forms with proteinases may be covalent 
[10,13,23-251 and other proteins present during 
activation of azM by proteinases may to some extent 
be simultaneously incorporated [27] as with TLCK- 
trypsin and insulin in [ 161. 
Here, we describe a model for the interaction of 
azM with trypsin and show that (YAM can bind trypsin 
in 3 distincts modes. At binding ratios of <2 mol 
trypsin/mol ~Y*M all of the trypsin is bound through 
sites not involving its active site leading to protection 
against inhibition by STI. Under these conditions 
56-67% of the complexed trypsin is bound covalently 
to azM in the sense that it is not dissociated by gel- 
filtration in 6 M guanidine-HCl after reduction and al- 
kylation while the rest is non-covalently bound. Addi- 
tional trypsin can be bound (presumably up to 2 mol/ 
mol cr,M) by interaction between the active site of 
trypsin and the ‘bait’ region of oczM [IO]. We also 
show that CHaNHz can compete with trypsin for the 
covalent binding to (YAM. 
2. Materials and methods 
Human azM was prepared by Zn’+-affinity chro- 
matography as in [ 131. Bovine trypsin was purified 
using a CHOM-column as in [ 16,271. The preparation 
was 88% active and only b-trypsin was seen on SDS- 
PAGE. 30 mg was iodinated with Na12’I (spec. act. 
15.5 Ci/mg I) (The Radiochemical Centre, Amersham) 
using the chloramine-T procedure [28]. Following gel 
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filtration on Sephadex G-25 (Pharmacia) in 50 mM 
CH3COONH4 @H 4.5) and dialysis against 1 mM HCl 
the 1251-labelled trypsin (mixture of /3- and ol-trypsin, 
76% active) was freeze-dried. The specific activity was 
1.06 X lo7 cpm/mg protein as determined in an LKB- 
Wallach Ultrogamma counter (Bromma). PTI was 
obtained from Novo (Bagsvard). The concentration 
of CQM was determined usingE280 ‘% = 9.1 [29] and 
M, 725 000 [30]. CH3NH2 - HCI was from Sigma 
(St Louis MO), iodoacetamide, BAPNA and guani- 
dine-HCl from Merck (Darmstadt). DTT was from 
Fluka (Buchs). Samples of cYzM-trypsin complex that 
were subjected to gel-chromatography on Sephacryl 
S-300 had been prepared from stock solutions of cvzM 
(15.0 I.IM in 0.05 M Na-phosphate, 0.1 M NaCl 
(pH 8.0)) and lz5 I-labelled trypsin (16 1 PM in 1 mM 
HCl). The stock solutions of crzM and trypsin (52% 
active) used for assay of trypsin protected from inhib- 
ition by ST1 were 13.5 PM and 106 PM, respectively. 
ST1 was 227 PM in 0.1 M Na-phosphate (pH 8.0) 
(buffer A). DTT and iodoacetamide were 0.5 M in 
water. PTI was 1.54 mM in buffer A. Buffer B con- 
sisted of 0.5 M Tri-HCl, 6 M guanidine-HCl (pH 8.0). 
3. Experimental and results 
The complexes between CY~M and trypsin formed 
under the conditions given in fig. 1,2 were subjected 
to gel chromatography under non-denaturing (fig.1) 
and denaturing (fig.2) conditions. The results shown 
in fig. 1,2 represent the ‘0’ and the ‘0’ experimental 
points, respectively, for [active trypsin]/[a2] = 2.14 
in fig.3. Fig.3 shows the molar ratio of trypsin bound 
(active plus inactive) to oc,M at varying concentrations 
of active trypsin added under different incubation 
and elution conditions, The initial slope of(X) and 
(o), representing trypsin bound to azM in the absence 
of CH,NH*, with or without subsequent addition of 
PTI, corresponds to 1.07 mol trypsin bound/m01 
active trypsin. The maximal amount of ‘*‘I-labelled 
trypsin that remained bound after addition of PTI 
was 2.25 mol/mol oc,M (0). 
The curve (X) shows that a,M can bind additional 
trypsin in the absence of PTI. At 4.28 mol active 
trypsin/mol a,M, 3.54 mol trypsin/mol CQM was 
bound under these conditions. At all incubation levels 
>2 mol trypsin/mol a,M the ‘*‘I-label was found 
either in the position of (Y*M or trypsin (or its autol- 
ysis products) (fig.l), indicating a relatively strong 
interaction between CY*M and trypsin at these sites. 
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Fig.1. Representative gel chromatography of CY,M treated 
with ‘251-labelled trypsin on Sephacryl S-300 (1 X 94 cm) in 
buffer A (non-denaturing conditions). Flowrate 4.0 ml/h; 
fraction size 1.0 ml. A 500 ~1 sample of ol,M was incubated 
with 100 ~1 lZ5 I-labelled trypsin and 300 ~1 buffer A for 2 min 
at room temperature. [active trypsin]/[a,Mj = 2.14. Then 
100 ~1 PTI was added and the mixture was loaded on the 
column. The absorbance at A,,, nm (-) and the radioac- 
tivity (--) of each fraction was determined. The recovery of 
both absorbance and radioactivity was 92%. The range of 
recovery for all experiments (-25) was 88-95%. The amount 
of trypsin bound to ol,M was determined by multiplying the 
total amount of trypsin (active plus inactive) with the fraction 
of radioactivity associated with the a,M peak. a,M-trypsin- 
PTI ternary complex was eluted in tubes 35-52, trypsin- 
PTI complex in 58-68 and PTI and low molecular mass autol- 
ysis products of trypsin in tubes 68-80. A control experiment 
with trypsin alone showed that -10% of the lZSI-label of 
trypsin was eluted in the 68-80 position. 
The presence of 0.13 M CH3NH2 decreases the 
amount of trypsin bound to CQM by 2-5% (fig.3 (0)). 
The results of gel chromatography following reduction 
and alkylation ofol,M-trypsin complex mixtures show 
that 56-67% of the trypsin bound firmly under the 
non-denaturing conditions (fig. 1) is still bound to 
a,M-fragments even under the denaturing conditions 
of fig.2 (fig.3 (0)). As evident from fig.3 (m) the amount 
of trypsin bound to a2M in the presence of 0.13 M 
CH3NH2 had decreased by -50% when examined after 
reduction and alkylation. 
Volume 128, number 1 FEBS LETTERS June 1981 
Y 
20 30 40 50 60 70 a0 
Fractions 
Fig.2. Representative chromatography of o,M treated with 
‘*51-labelled trypsin on Sephacryl S-300 (1 X 93 cm) in 
buffer B (denaturing conditions). o&I (250 ~1) was incubated 
with 50 ~1 ‘ZSI-labelled trypsin and 100 *I buffer A for 2 min. 
Then SO ~1 PTI was added followed by 100 ~1 1 M Tris-HCI, 
(pH 8.5), 500 mgguanidine-HCl and 20 ~1 DTT solution. 
After reduction for 1 h at room temperature SO& ICH,CONH, 
was added. Following ~lkylation for 10 min the sample was 
loaded on the column (both equilibrated and eluted with 
buffer B). Flowrate 4.0 ml/h; fraction size 1.3 ml. Absor- 
bance at 280 nm (-); radioactivity (---). The recoveries 
of both protein and radioactivity were -90%. Tubes 23-33 
apparently contained trypsin bound to ~*~-fragments and 
34-54 unbound @-trypsin and fragments derived from 
cu-trypsin. Tubes 55-65 contained PTI. Low molecular mass 
autolysis products from trypsin were eluted in tubes 65-70 
and DTT in tubes 66-76. The materi~in~ubes40-48 prob.- 
ably represents fragments of o,M derived as a result of slight 
digestion with trypsin. 
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Fig.4. Titration of trypsin bound to cu,M and protected from 
inhibition by ST1 in the absence (0) or presence (n) of 0.13 M 
CH,NH,. For experiments performed in the absence of 
CH,NH, 100 ~1 c*,M (13.5 PM) was mixed with 150-72 E;I 
buffer A. After incubation for 60 s with O-39 ~1 trypsin 
(106 PM), O-39 ~1 ST1 (227 PM in buffer A) was added. 
After incubating 120 s a 100 rl aliquot was removed and 
added to a cuvette containing SO pi BAPNA (20 mM in dimeth- 
yisulfoxide) and 1850 ~1 buffer A. The increase in absor- 
bance at 405 nm was recorded for 120 s. For experiments 
performed in the presence of CH,NH, 80-42.5 ~1 buffer A 
was mixed with 27.5 ~1 CH, NH, (1 M in buffer A) followed 
by addition of 100 ~1 cu,M. After incubation for 10 s, 2.5-40 ~1 
trypsin was added. After further incubation for 60 s, 2.5-40 Eil 
ST1 was added followed by 37.5-O ~1 buffer A. Then a 100 yl 
aliquot was removed after 120 s and assayed asabove. All 
incubations and assays were done at room temperature 
(22-23°C). 
Fig.4 shows that the amount of trypsin protected 
from i~bitio~ by ST1 is 1.88 mol/mol crzM regard- 
less of whether the ~&G-trypsin complexes were 
formed in the absence or the presence of 0.13 CH&&. 
Fig.3. Binding of “2SI-labelled trypsin to o,M at different con- 
centrations of trypsin under non-denaturing and denaturing 
conditions. Mixtures of ar,M (SO0 ~1 or 250 ~1) withva~ing 
amountsof”~I-1abe~ed trypsin (final vol. 1000 ).d or SO0 ~1, 
respectively) had been subjected to gel chromatography in 
buffer A (f&l). Samples were prepared in the absence (0) or 
the presence (0) of 0.1 M CH,NH,. Parallel samples prepared 
in the absence (0) or the presence (9) of 0.13 M CH,NH, 
were reduced, ~arboxa~dome~ylated and subjected to gel 
chromatography in buffer B (fig.2). Samples were also pre- 
pared in the absence ofCH, NH, and PTI and subjected to gel 
chromatography in buffer A (Xl. An additional point (2.97 
mol trypsin bound/ mol cu,M for 8.56 mol active trypsin/mol 
o,M) is not shown here. 
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4. Discussion 
As shown in [ 131 the cleavage of the thiol esters 
of (YZM shows a 4: 1 stoichiometry between appearance 
of SH-groups and trypsin at <l mol trypsin/mol o(~M. 
Under these conditions it appears that cleavage of two 
‘bait’ region sequences is required for binding one tryp- 
sin molecule to ol,M in a mode resulting in protection 
against ST1 [7-91. Thus only l/2 of the thiol ester 
cleavage is strictly correlated with ‘bait’ region cleavage 
[ 131. Complete cleavage of all 4 ‘bait’ regions occurs 
at >2 mol trypsin/mol (Y*M resulting in appearance of 
4 mol SH/mol azM [ 131. Furthermore, maximally 
2 mol trypsin/mol (YAM can be protected against inhib- 
ition by ST1 [7-9,131. These results indicate that the 
cleavage reactions in a2M leading to formation of pro- 
tected cu2M-trypsin complexes take place in at least 
2 steps, namely reaction (1): 
cy2 M t trypsin f azM . trypsin 
(cleavage of 2 ‘bait’ regions and 4 thiol esters) 
and reaction (2): 
crzM . trypsin + trypsin 2 (YAM . trypsin* 
(cleavage of the remaining 2 ‘bait’ regions). 
Fig.5 shows a schematic model of the reaction 
paths in the formation of cY*M-trypsin complexes, 
compatible with the available evidence. Prior to cleav 
age in the ‘bait’ region trypsin and crzM form a non- 
covalent complex (binding mode I) engaging the active 
site of trypsin and the ‘bait’ region of one of the sub- 
units of crzM. Since the tetrameric CY*M is assembled 
from 2 ‘half molecules’ ofM, 360 000, each consisting 
of 2 disulfide-bridged J4, 180 000 subunits [30] and 
since aZM can bind anhydrotrypsin reversibly (2 mol/ 
mol a,M) [26] it is likely that the ‘half molecules’ are 
the functional units of oc,M. 
Following initial non-covalent complex formation 
one of the possibly two reversibly bound trypsin mol- 
ecules initiates the activation of a,M by cleaving the 
‘bait’ region sequence in 2 subunits at a specific Arg- 
Leu bond [IO]. This triggers a conformation change 
in c+M [7,9] affecting all 4 subunits and rendering 
the thiol ester in each subunit of CY~M susceptible to 
nucleophilic attack [ 131. This process generates 
‘nascent’ azM-trypsin complex which exists only for 
a short time [ 161. Accompanying the conformational 
change the first trypsin molecule, already positioned 
due to the interaction between its active site and the 
‘bait’ region of cu2M, is entrapped within the ‘half 
molecule’. The trypsin thus entrapped is now bound 
in its final binding site, involving sites on OL~M different 
130 
from the ‘bait’ region and sites on trypsin different 
from the active site [lo]. 
Since the conformational change in (Y*M is effected 
by the first trypsin to cleave azM it follows that the 
second trypsin, presumably also positioned at the 
‘bait’ region of one of the remaining 2 subunits is like- 
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Fig.5. Schematic model of the reaction paths in the forma- 
tion of a,M-trypsin complexes. The ‘half molecules’ of ol,M 
consisting of two disulfide-bridged subunits are represented 
by pairs of squares, connected by a thick solid line. The 4 
square assembly can exist in 2 states: an open form (native 
ol,M) and a compact form (oi,M-trypsin complex). The ‘bait’ 
region is either represented by a filled triangle at one corner 
in each subunit (native oc,M) or by a disrupted corner (cleaved 
a,M). The thiol ester in each subunit isrepresented by CO-S. 
The intermediate acyl group in ‘nascent’ a,M is shown by 
*CO. Trypsin is shown as an open circle when bound to the 
‘bait’ region of or,M and as crosshatched circle when entrapped 
in ol,M. State 1 refers to the initial complex between ol,M and 
trypsin (binding mode I). State II indicates the cleavage of 
two ‘bait’ region sequences by one trypsin molecule. State 
III refers to ‘nascent’ a,M. In this state two trypsin molecules 
are entrapped within one cu,M molecule due to the conforma- 
tional change and the thiol esters have become cleaved result- 
ing in appearance of free SH-groups. The acyl groups react 
rapidly with a fraction of the entrapped trypsin molecules 
to form covalent ol,M-trypsin complexes (state IV). Other 
nucleophiles that happen to be present can also react with 
the acyl groups (CO-X). State IV constitutes the final a,M- 
trypsin complex and contains trypsin boundin modes II and III. 
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wise bound to CY,M by entrapment. During this bind- 
ing the remaining 2 subunits of +M are also cleaved 
at the same Arg-Leu bonds in their ‘bait’ region. It is 
not clear which structures in a,M constitute the final 
binding sites for trypsin or whether the two binding 
sites are identical. 
The activated acyl-groups in nascent cuzM-trypsin 
complex derived from the originally thiol esterified 
Glx-residues 113,141 may subsequently participate in 
‘acyl transfer’ reactions [ 131 leading to formation of 
covalent cYzM-trypsin complexes. The fraction of acyl 
groups reacting with suitably oriented nucleophilic 
groups on the surface of trypsin may be expected to 
vary, dependent on the presence of other nucleophiles 
[ 161 besides water. Since asM-trypsin complexes 
formed at 2 mol trypsinlmol cu,M give rise to Mr 
85 000 fragments on reducing SDS-PAGE [ 1,7-91 it 
appears that the larger part of trypsin bound covalently 
to oZM only binds via 1 acyl group/trypsin molecule. 
However, trace amounts of components having higher 
Mr values are always found indicating that the activated 
acyl groups may cause a low degree of crosslinking of 
the iMr 85 000 fragments or that trypsin may bind 
covalently to 2 Iw, 85 000 fragments. 
Entrapped trypsin constitutes trypsin bound in 
mode II, while the fraction of trypsin that is further- 
more bound covalently constitutes trypsin bound in 
mode III. In both of these modes the trypsin bound is 
protected against inl~bition by STI. 
The initial slope (fig.3 (X), (0)) corresponds to 
1.07 mol trypsin bound/m01 active trypsin. This shows 
that part of the inactive fraction constituting 24% of 
the total trypsin in the preparation of “251-labelled 
trypsin used here must have been bound to ‘nascent’ 
cr,M-trypsin complex in addition to the binding of 
active trypsin as anticipated [ 161. When 02M was 
incubated with trypsin at ratios 52 mol active trypsinj 
mol CQM all the active trypsin bound to azM (maxi- 
mally -1.85-l .90 mol/mol azM for different prepa- 
rations) was protected from i~bition by STI, regard- 
less of whether 88% or 52% active trypsin was used. 
This result shows that binding of active trypsin result- 
ing in protection of its active site takes place in pref- 
erence to binding of inactive forms in binding modes 
II and III. The difference in the maximal amount of 
trypsin bound to ar2M (2.25 mol/mol, fig.3 (0)) and 
the amount protected (~1.8.5-1.90 mollmol) may 
represent binding of not only inactive trypsin but also 
active trypsin in a mode where it can be inhibited by 
STI. 
Fig.3 (X) shows that at 4.28 mol active trypsin 
added/m01 CQM, 3.54 mol trypsin is bound/m01 a2M. 
This result demonstrates that additional binding of 
trypsin (presumably up to 2 mol/mol CQM) can take 
place in a mode different from modes II and III. This 
additional binding can be reversed by PTI (fig.3 (0)) 
indicating that the trypsin is bound via its active site. 
The binding sites on crzM are most likely contributed 
by the ‘bait’ regions of 2 of the 4 subunits and are 
presumed to mediate binding analogous to binding 
mode I. Regarded in this way the ‘bait’ region con- 
stitutes a trypsin binding site that corresponds to the 
~~bitor site of ‘classical’ inl~bitors such as PTI or 
ST1 131,321. 
Fig.3 (0) shows that the amount of trypsin bound 
to crZM in the presence of 0.13 M CH,NH2 is only 
reduced by 2-5%, despite the simult~eous binding 
of 2.5-3.0 mol CH,NH,/mol ‘nascent’ oZM trypsin 
complex under those conditions [ 161. However, 
CH,NH2 clearly competes with trypsin for the covalent 
binding sites of oZM since the amount of trypsin which 
remains bound, when examined after reduction and 
alkylation (conditions of fig.2) had decreased by -50% 
(fig.3 (o), (n)). These results, and the earlier results 
showing that prior covalent binding of CH3NH2 to 
a,M precludes subsequent binding of trypsin to arzM 
[ 13,151 strongly support the model presented in fig.5 
indicating that the covalent incorporation of trypsin 
into 02M occurs on the originally thiol-esteri~ed Glx- 
residues [ 131. The maximal amount of trypsin bound 
covalently to olM is -1.3 mol/mol 02M at 2 mol 
trypsim’mol CQM is compared with 1.85-l -90 mol 
trypsin protectedjmol, here. 
Evidently, covalent attachment is not a prerequisite 
for binding trypsin in a mode that confers protection 
of its active site against inhibition by STI. Further- 
more, the titration curves for cYzM-trypsin complexes 
formed in the absence or the presence of 0.13 M 
CHaNH2 are identical (fig.4). This strongly indicates 
that the main factor responsible for the formation of 
protected cuzM-trypsin complexes is the conforma- 
tional change in (YAM triggered by specific limited pro- 
teolysis in the ‘bait’ region. The simultaneous incor- 
poration of 2.5-3.0 mol CH~NH~/mol c+M only 
affects the distribution of trypsin bound in the pro- 
tected modes II and III. The results shown in fig.4 
also indicate that the kinetic properties of trypsin 
bound in these modes are very similar. 
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